scispace - formally typeset
M

Marion Rother

Researcher at Max Planck Society

Publications -  12
Citations -  449

Marion Rother is an academic researcher from Max Planck Society. The author has contributed to research in topics: Innate immune system & Zika virus. The author has an hindex of 7, co-authored 12 publications receiving 348 citations. Previous affiliations of Marion Rother include Otto-von-Guericke University Magdeburg.

Papers
More filters
Journal ArticleDOI

EphrinA2 Receptor (EphA2) Is an Invasion and Intracellular Signaling Receptor for Chlamydia trachomatis

TL;DR: These findings provide the first evidence for a host cell surface receptor that is exploited for invasion as well as for receptor-mediated intracellular signaling to facilitate chlamydial replication and subverts the host cell and induces apoptosis resistance.
Journal ArticleDOI

Chlamydia infection depends on a functional MDM2-p53 axis.

TL;DR: It is demonstrated that inhibition of the p53–MDM2 interaction is sufficient to disrupt intracellular development of Chlamydia and interferes with the pathogen’s anti-apoptotic effect on host cells, highlighting the dependency of the pathogenic on a functional MDM2-p53 axis and lends support to a potentially pro-carcinogenic effect of chlamydial infection.
Journal ArticleDOI

Critical Role of Methylglyoxal and AGE in Mycobacteria-Induced Macrophage Apoptosis and Activation

TL;DR: Elevated levels of methylglyoxal (MG), a small and reactive molecule that is usually a physiological product of various metabolic pathways, and advanced glycation end products (AGE) during mycobacterial infection of macrophages, leading to apoptosis and activation of macocytes are demonstrated, providing first evidence for the involvement of MG and AGE in TB.
Journal ArticleDOI

Klebsiella pneumoniae targets an EGF receptor-dependent pathway to subvert inflammation.

TL;DR: By applying a high‐throughput siRNA gain‐of‐function screen interrogating the human kinome, 17 kinases are identified that when targeted by siRNA restored IL‐1β‐dependent NF‐κB translocation in infected cells and it is proposed that agents targeting this signalling pathway might provide selective alternatives for the management of K. pneumoniae pneumonias.